Vault-13

EIGER BIOPHARMACEUTICALS INC CLDN

COM NEW · Common Stock · CUSIP 28249U204

2 institutional holders -23 vs Q1 2024
146,424146.4k shares reported held*
$1.9mreported value*
0 new 0 added 1 reduced 23 sold out net sold ≈ $6.2m (-521.1k shares)

* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Implied quarter-end price ≈ $12.65.

Trends to Q2 2024

Institutional holders

Managers reporting a position, each quarter

0102030Q1 24: 25Q2 24: 22Q1 24Q2 24
Numbers
QuarterHolders
Q1 202425
Q2 20242

Biggest buyers

None

Biggest sellers

AMERIPRISE FINANCIAL INC Sold out -250,178-250.2k
Simplify Asset Management Inc. Sold out -90,000-90.0k
Accretive Wealth Partners, LLC Sold out -63,150-63.1k
683 Capital Management, LLC Sold out -29,660-29.7k
VANGUARD GROUP INC Sold out -28,201-28.2k
BlackRock Inc. Sold out -19,109-19.1k
GEODE CAPITAL MANAGEMENT, LLC Sold out -12,652-12.7k
RENAISSANCE TECHNOLOGIES LLC Sold out -11,102-11.1k
RBF Capital, LLC Sold out -10,971-11.0k
Tower Research Capital LLC (TRC) Sold out -1,948-1.9k

Holders, Q2 2024

#ManagerLocationShares Value% of their portfolioChangeShares change
1 Propel Bio Management, LLC 1.20% of their portfolio Los Angeles, CA 146,381146.4k $1.9m $1.9m 1.20% Unchanged
2 OSAIC HOLDINGS, INC. 0.00% of their portfolio SCOTTSDALE, AZ 4343 $543 $543 0.00% Reduced -288 -288